Omecamtiv Mecarbil, Omecamtiv Mecarbil, Matching Placebo, Omecamtiv Mecarbil
CY 1033
Phase 3 small_molecule active
Quick answer
Omecamtiv Mecarbil, Omecamtiv Mecarbil, Matching Placebo, Omecamtiv Mecarbil for Heart Failure With Reduced Ejection Fraction is a Phase 3 program (small_molecule) at Cytokinetics (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cytokinetics (Ireland) Limited
- Indication
- Heart Failure With Reduced Ejection Fraction
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active